+134%

est. 2Y upside i

Healthcare

Robotic production capacity for the pharma manufacturing industry

Rank

#210

Sector

Biotechnology / Robotics

Est. Liquidity

~2Y

Data Quality

Data: Low

Multiply Labs presents a high-risk, high-reward opportunity.

Last updated: July 19, 2026

Bull (10%)+400%

Bull case: Successful IPO window or category leadership drives multiple expansion to 10x, with projected 2027 revenue of $12.5M yielding $125M exit. Dilution reduces net upside to 400%.

Base (55%)+234%

Base case: Multiple converges to public comp average of 6x, exit value $75M. 20% dilution reduces net upside to 234%.

Bear (35%)-100%

Bear case: Multiple compresses to 3x, exit value $37.5M, below total funding of $41.3M, rendering common stock worthless after preference stack.

Est. time to liquidity~2.0 years

Preference Stack Risk

severe

Funding Intensity

195%

Total funding of $41.3M implies preferred stack exceeds current equity value, endangering common stock in downside.

Dilution Risk

high

With last round in 2023 and high capital intensity, a dilutive raise within 24 months is likely, assumed 20% dilution.

Secondary Liquidity

none

No secondary market liquidity noted; illiquid until exit.

Robotics Software 3 roles

Software 2 roles

Biosciences 1 role

Engineering Leadership 1 role

Finance 1 role

Open Application 1 role

View all 16 open roles at Multiply Labs

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Multiply Labs's data — designed to show you've done your homework.

  • 1

    How does Multiply Labs' robotic platform differentiate from in-house automation efforts by large pharma incumbents like Thermo Fisher?

  • 2

    What is the recurring revenue component as a percentage of total revenue, and how do subscription agreements scale with customer growth?

  • 3

    Given the high preference stack and likely dilutive raise, how does the company plan to align employee equity incentives with long-term value creation?

Community

Valuation Sentiment

Our model estimates +134% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.